From 10–12 September at BITEC Bangkok, the inaugural event – held in collaboration with Medical Fair Thailand – unites global leaders in AI, biotech, smart hospitals, and telemedicine to shape Asia’s healthcare transformation....
Sandstone’s Easydrip™ Plus launches in Uzbekistan with premium features and everyday pricing; Ming Shen outlines the education-first approach and regional expansion plans....
DHL’s new €10M pharmaceutical hub and expanded cold-chain network reinforce Singapore’s position as Asia Pacific’s life sciences and healthcare logistics powerhouse....
Mahesh Yermal, Head of Marketing, Vision Care (Consumer and Pharma), Alcon, shares how India became the launchpad for the company’s next-generation lens technology and its role in shaping the future of eye health....
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine....
Regulatory milestone supports China’s reproductive health goals by enabling radiation-free, high-accuracy ultrasound imaging to assess fallopian tube patency and uterine abnormalities in women. ...
Regulatory green light marks full commercial launch of LungVision, enhancing early lung cancer detection through AI-driven 3D imaging for more precise bronchoscopic diagnostics....
Dr Ashton Harper, Global Medical Affairs Lead for Neurosciences at Roche Diagnostics, discusses how the CE-marked blood test enhances early detection, reduces invasive diagnostics, and aligns with the advent of disease-modifying therapies....
Sandeep Brar, Vice President of Clinical and Regulatory at Medtronic, shares insights on the scientific rationale, catheter design, and the future of multi-organ denervation in managing hypertension. ...
In April, Health Secretary Robert F. Kennedy Jr. announced plans to dramatically reduce animal testing at U.S. health agencies. The FDA followed with a commitment to phase out animal studies in areas like monoclonal antibody development, favoring in vitro systems and artificial intelligence instead. ...
